ARVO 2025: Shortened, maintained, or extended dosing intervals through 96 weeks in PHOTON
May 30th 2025At ARVO 2025, in Salt Lake City, Utah, Dilsher Dhoot, MD, FASRS, and Mark Barakat, MD, talked about the PHOTON trial, 8 mg versus 2 mg during the matched dosing phase, and outcomes of shortened, maintained, or extended dosing intervals
ARVO 2025: Efficacy of DIMS lenses in slowing myopic shifts among pre-myopic preschoolers
May 25th 2025At ARVO 2025, in Salt Lake City, Utah, Hsin-Yu Yang talked about the 9-month results from her study on the effectiveness of DIMS spectral lenses in myopic retardation for the pre-myopic preschoolers in Taiwan.
ARVO 2025: Using graph neural networks to differentiate between fast and slow glaucoma progressors
May 23rd 2025At ARVO 2025, in Salt Lake City, Utah, Patipol Tiyajamorn, talked about his poster on using graph neural networks to identify fast glaucoma progressors solely using optic nerve head morphology at a single time point
ARVO 2025: Inflammatory eye disorders in hidradenitis suppurativa patients
May 23rd 2025At ARVO 2025, in Salt Lake City, Utah, Anisha Kasi talked about her presentation on how her team used the TriNetX database, a large database of over 150 million patients worldwide, to validate the connection between hidradenitis suppurativa and inflammatory eye conditions.
Long-Term Outcomes After Nonimplant MIGS Procedure
May 13th 2025A panelist discusses how nonimplant MIGS, such as viscocanaloplasty and viscoelastic delivery devices, offer long-term IOP reduction and medication savings, emphasizing their benefits for early intervention and improved postoperative quality of life, while noting limitations for more advanced glaucoma conditions.
Case 2: A Case of CEIOL Plus Ab Interno Canaloplasty
Published: May 13th 2025 | Updated: May 13th 2025A panelist discusses how Via360 viscodilation effectively reduced IOP and improved vision in a 90-year-old woman with chronic angle-closure glaucoma, offering a suitable surgical solution given her complex medication regimen and poor adherence.
Case 1: A Case of Open-Angle Glaucoma Treated With Canaloplasty and Trabeculotomy
Published: May 13th 2025 | Updated: May 13th 2025A panelist discusses how combining cataract surgery with canaloplasty and trabeculotomy using the Via360 device offered an effective MIGS solution for a patient with open-angle glaucoma and poor medication adherence, reducing IOP while minimizing the need for filtering surgery.
Selecting the Rights MIGS Procedure for Individual Patients
Published: May 13th 2025 | Updated: May 13th 2025A panelist discusses how selecting the right MIGS procedure based on individual patient factors—such as glaucoma severity, angle anatomy, and target IOP—can optimize outcomes and personalize glaucoma management.
RWC 2025: Alan J. Franklin, MD, PhD on the use of intraoperative fluorescein angiography
May 9th 2025In this conversation, Franklin discussed a research study on intraoperative fluorescein angiography in surgical procedures, highlighting significant advancements in surgical visualization and patient outcomes.